Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FDPS | P14324 | 11/20 | 0.48 |
| ▸ | GRM4 | Q14833 | 1/20 | 0.44 |
| ▸ | SMPD1 | P17405 | 3/20 | 0.39 |
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | PDE3A | Q14432 | 2/20 | 0.36 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.36 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.36 |
| ▸ | PPARD | Q03181 | 1/20 | 0.33 |
| ▸ | GGPS1 | O95749 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6777913 | 0.86 | FDPS (0.44) | FDPSGRM4SMPD1LMNAPDE3A | |
| SCHEMBL6771983 | 0.82 | FDPS (0.47) | FDPSGRM4SMPD1GGPS1 | |
| SCHEMBL5918828 | 0.80 | FDPS (0.62) | FDPSGRM4SMPD1GGPS1 | |
| SCHEMBL1052690 | 0.79 | — | — | |
| SCHEMBL20533249 | 0.75 | ALDH1A1 (0.45) | FDPSGRM4SMPD1LMNA | |
| SCHEMBL6772322 | 0.75 | FDPS (0.42) | FDPSGRM4SMPD1LMNAPDE3A | |
| SCHEMBL10324944 | 0.75 | ALDH1A1 (0.45) | FDPSGRM4SMPD1LMNA | |
| SCHEMBL10389143 | 0.74 | LMNA (0.41) | FDPSGRM4LMNAPDE3AADRB3 | |
| SCHEMBL1285892 | 0.74 | FDPS (0.61) | FDPSGRM4SMPD1LMNAPDE3A | |
| SCHEMBL10640273 | 0.74 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040197293-A1 | Anionic polyurethanes with elastic property | L'OREAL S.A. (FR) | 2004-10-07 | — | — | US | claimed |
| US-20040197293-A1 | Anionic polyurethanes with elastic property | L'OREAL S.A. (FR) | 2004-10-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040197293-A1 | Anionic polyurethanes with elastic property | PUF60, PHOSPHO1, PLA2G2C | FDPS 2917/4885GRM4 2473/4885SMPD1 1987/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.